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Patients frequently report high levels of physical symp-
toms, such as itch and pain, which do not completely 
correspond to pathophysiological findings, possibly in-
dication heightened sensitivity to physical symptoms. 
Sensitivity to itch and pain is thought to be affected by 
processes such as attentional focus on bodily sensations. 
We investigated the role of attentional focus in sensitivity 
to various somatosensory stimuli evoking both itch and 
pain sensations in healthy female subjects. Different me-
chanical, chemical and electrical stimuli of quantitative 
sensory testing were applied. Attentional focus on bodily 
sensations was measured using validated questionnaires. 
The results indicated that focusing on bodily sensations 
is associated with higher levels of experienced itch and 
pain but not with tolerance to stimuli. This suggests 
that attentional focusing on bodily sensations is a me-
chanism responsible for sensitivity to different physical 
sensations, such as itch and pain. Key words: quantitative 
sensory testing; attentional focus; sensitivity; itch; pruri-
tus; pain; anxiety sensitivity. 
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Patients often report levels of itch and pain that are not 
correlated with other signs of disease, with the severity 
of the disease or with the intensity of itch and pain ex-
pected according to pathophysiology. There is increasing 
evidence that heightened sensitivity to physical sensa-
tions plays a role in the maintenance and aggravation of 
complaints such as itch and pain. For example, patients 
with chronic itch or pain have been shown to be generally 
more sensitive to itch and pain, respectively, than healthy 
controls (1–4). Information processes, such as attentional 
focus towards sensations, are thought to play a main 
role in sensitivity to different complaints, such as pain 
(5–9). The extent to which individuals focus on bodily 
sensations is also of importance in conditions associated 
with chronic pain. For example, there are indications 
that patients with chronic pain have heightened attention 
towards pain-related information (10–12). Attention also 
plays a role in the response to experimentally applied pain 
stimuli (13–15). Given that there is an overlap in psy-
chophysiological mechanisms of itch and pain (16–18), 
attentional focus could also play a role in sensitivity to 
itch. There is preliminary evidence that patients with 
psoriasis display heightened attentional focus on disease-
specific words (including itch words) compared with 
healthy subjects (19). However, the role of attentional 
focus on bodily sensations in itch has not been investi-
gated systematically. In addition, individual differences 
in personality are thought to be partly responsible for a 
heightened perception of sensations or hypervigilance 
to symptoms. For example, subjects relatively high in 
physical anxiety sensitivity or in neuroticism pay more 
attention to physically threatening stimuli and are more 
hypervigilant to physical symptoms (20–22). Conse-
quently, personality characteristics of anxiety sensitivity 
and neuroticism may affect the relationship between 
attentional processes and sensitivity to somatosensory 
stimuli (6, 13, 23–26). 
Taking all these factors into account, it is likely that 
focusing attention on bodily sensations plays a role 
in the experience of sensations of both pain and itch. 
Since there is some evidence that both itch and pain 
are affected by similar mechanisms of sensitization (2, 
16, 18), with both patients with chronic itch and pain 
being relatively more sensitive to somatosensory stimuli 
than healthy controls, comparison of itch and pain may 
clarify the differences in peoples’ sensitivity to different 
bodily sensations such as itch and pain. However, no 
studies have investigated the role of attentional focus 
on bodily sensations in sensitivity to itch and pain. The 
aim of this study was to investigate the role of atten-
tional focus on bodily sensations in the sensitivity to 
various somatosensory stimuli, including mechanical, 
electrical and chemical stimuli, eliciting sensations of 
itch and pain, controlling for the role of the personality 
characteristics anxiety sensitivity and neuroticism. We 
hypothesized that individuals with a greater attentional 
focus on bodily sensations would be more sensitive 
to the test stimuli; in particular, that attentional focus 
would be related to the higher reports of itch and pain. 
In addition, it is suggested that attentional focus might 
be affected by anxiety-based personality characteristics 
(e.g. neuroticism and anxiety sensitivity) and that it 
Role of Attentional Focus on Bodily Sensations in Sensitivity to 
Itch and Pain
Antoinette I. M. VAN LAARHOVEN1, Floris W. KRAAIMAAT1, Oliver H. WILDER-SMITH2 and Andrea W. M. EVERS1
1Department of Medical Psychology and 2Pain and Nociception Research Group, Department of Anaesthesiology, Pain and Palliative Medicine, Radboud 
University Nijmegen Medical Center, Nijmegen, The Netherlands
47Attentional focus in sensitivity to itch and pain
would mediate the relationship between personality 
characteristics and sensitivity to itch and pain.
MATERIALS AND METHODS
Participants
Thirty-two women (mean age 38 years, standard deviation 
(SD) 18 years) without acute or chronic itch or pain complaints 
were recruited via advertisements. Subjects with a minimum 
age of 18 years were included. Exclusion criteria were: severe 
morbidity (e.g. multiple sclerosis, diabetes mellitus); severe 
psychiatric disorders; pacemaker use; and levels of current itch 
and pain above 1.0 on a scale of 0–10. Of the subjects 59% 
had completed secondary education and 41% had completed 
tertiary education. Forty-four percent of the subjects were 
married or lived with a partner. The protocol was approved 
by the regional medical ethics committee and all participants 
gave their informed consent prior to the investigation. On ar-
rival at the test facility, participants were informed about the 
procedure and asked about their menstrual cycle, smoking, and 
use of medication, and intake of caffeine, and alcohol over the 
previous 24 h. Participants had earlier been asked not to drink 
black tea or coffee 1 h before testing. Three subjects had taken 
medication for high blood pressure, of which one had taken a 
selective serotonin reuptake inhibitor antidepressant and one 
had taken an antihistamine within 24 h prior to testing. 
General procedure
Self-report questionnaires were sent to the participants one week 
before testing. On the day of testing, the participants were asked to 
indicate the current level of itch and pain at the start of the test on 
a visual analogue scale (VAS) ranging from 0 to 10. Mean levels of 
current itch and current pain were 0.1 (SD = 0.3) and 0.2 (SD = 0.4), 
respectively. Subsequently, quantitative sensory testing (QST) 
was performed using mechanical, electrical, chemical and thermal 
stimuli, in the following order: tactile stimulation, electrical sti-
mulation, histamine iontophoresis, cold stimulation and capsaicin 
application. The same investigator administered all stimuli. The 
inter-stimulus interval was at least 10 min, with a 15-min interval 
after the histamine and cold pressor stimuli. On the day of testing, 
subjects were informed about the procedure and familiarized with 
the stimuli in a pre-test trial. Subjects were told that stimuli could 
provoke any type of sensation, for example itch and pain. After 
each stimulus, subjects were asked to rate their perceived sensation 
using a 10-point VAS for both itch and pain, ranging from no itch/
pain (0) to the worst itch/pain imaginable (10). 
Self-report questionnaires
Attentional focus on the occurrence of bodily sensations. The 
Body Sensations Questionnaire (BSQ) (27) was used as a measure 
of attentional focus on the occurrence of bodily sensations. This 
questionnaire containing 15 items concerning bodily sensations 
was used by asking subjects to rate the frequency of bodily sen-
sations (e.g. heart palpitations, dizziness or sweating) occurring 
when in a nervous or feared situation. Each item was rated on a 
5-point Likert scale, ranging from “the sensation never occurs” 
to “the sensation occurs almost always or always”. The total 
score was obtained by calculating the mean score of the items. 
Cronbach’s alpha for the BSQ in the present study was 0.66. 
Attentional focus on bodily sensations. The tendency to attend 
to internal bodily sensations was measured with the Body Vigi-
lance Scale (BVS) (28), consisting of four items, three of which 
assess the degree of attentional focus, perceived sensitivity to 
changes in bodily sensations, and the average amount of time 
spent attending to sensations. The fourth item contains 13 items 
concerning anxiety-related bodily sensations (heart palpitations, 
chest pain, numbness, tingling, shortness of breath, faintness, 
vision changes, dizziness, hot flash, sweating/clammy hands, 
upset stomach, nausea, choking/throat closing). Items were 
rated on a 10-point VAS. The ratings for the bodily sensations 
of item 4 were averaged to obtain an overall score for item 4. 
The total score of BVS is the sum of items 1 to 4. Cronbach’s 
alpha for the BVS in the present study was 0.82.
Personality characteristics. The Anxiety Sensitivity Index 
(ASI) (29) measured the subjects’ fear of bodily sensations 
that are interpreted as having potentially harmful, physical or 
psychological, consequences. The ASI consists of 16 items, 
rated on a 5-point Likert scale (1 = very little, 2 = little, 3 = some, 
4 = much, 5 = very much). The total score was obtained by sum-
ming the scores for the 16 items (range 0–64). The Cronbach’s 
alpha for the ASI in the present study was 0.91. In order to 
measure neuroticism, the neuroticism subscale (22 items) of 
the Eysenck Personality Questionnaire (EPQ) was used (30). 
In the present study the Cronbach’s alpha was 0.88.
Somatosensory stimuli
Mechanical stimulation. Twenty Semmes-Weinstein von Frey 
calibrated monofilaments were used in a range of 0.00045 to 447.0 
grams. Filaments were applied to the non-dominant forearm (2 cm 
distal to the lateral epicondyle of the humerus, C5 dermatome) 
once vertically and with increasing force, while avoiding contact 
with body hair. Subjects were asked to report the Aδ-fibre thres-
hold as well as the itch and pain ratings for that threshold (2).
Electrical stimulation. Cutaneous electrodes were applied to the 
non-dominant forearm (2 cm distal to the lateral epicondyle of 
the humerus, C5 dermatome) and the trapezius on the dominant 
side. The electrical tolerance thresholds were measured using 
a constant current nerve stimulator (MultiStim Vario, Pajunk, 
Geisingen, Germany). Electrical stimuli consisted of 0.3-ms 
pulses at 100-Hz frequency with a continuous increasing intensity 
of about 0.2 mA/s applied until the subject reported the tolerance 
threshold which was defined by “the moment that the sensation 
becomes unbearable and you want to stop immediately”. After 
a pretest trial with the trapezius, the tolerance threshold was 
determined on the forearm and then subjects were asked to rate 
itch and pain intensity at the tolerance threshold. The mean of 
two repeated threshold measurements was calculated (2).
Histamine iontophoresis. Histamine (31, 32) was applied by 
means of an iontophoresis system (Chattanooga Group, Hixson, 
USA). Histamine dihydrochloride (0.5%) was dissolved in a gel 
of 2% methylcellulose in distilled water and 2.5 ml was placed 
in an electrode (Chattanooga Ionto Ultra Electrode medium, 
Hixson, USA). This electrode was applied to the dominant fore-
arm, 2 cm distal to the lateral epicondyle of the humerus (C5 
dermatome). The reference electrode was applied to the skin of 
the lateral side of the triceps brachial muscle. Current level was 
set at 0.4 mA and histamine was delivered for 2.5 min. Subjects 
were asked to rate itch and pain during histamine application 
every 30 sec. Mean scores for itch and pain during histamine 
application were calculated.
Capsaicin application. Capsaicin (Bufa Spruyt-Hillen, Utrecht, 
The Netherlands) was applied topically, according to the guide-
lines of Green (33), in a non-evaporative vehicle (Lanette I cream). 
Capsaicin cream in a concentration of 1% was applied to the volar 
aspect of the dominant forearm laterally (2 cm proximal of the 
distal wrist crease, dermatome C5) over an area of 10 cm2 for 7 min. 
Levels of itch and pain were scored every minute during application 
and the mean scores for itch and pain were calculated. 
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Cold pressor test. Subjects were instructed to place their domi-
nant hands in a tank of ice water at about 4°C (mean temperature 
4.3°C; SD = 0.6) as long as possible, until they could no longer 
tolerate it. The participants were not aware of the upper time 
limit of 3 min (34). The immersion time was recorded and the 
level of itch and pain during the test was assessed immediately 
after the subjects had withdrawn their hands. 
Statistical analysis
All analyses were performed using SPSS 16.0 for Windows. 
All stimuli evoked both itch and pain, except the cold pressor 
test, for which only 2 subjects had itch scores above 1.0 (mean 
0.1, SD 0.5) and the capsaicin application, for which only 3 
subjects had pain scores above 1.0 (M = 0.3, SD = 0.5). Con-
sequently, these variables (itch scores for the cold pressor test 
and pain scores for capsaicin) were not included in analyses. 
Variables were checked for normal distribution. Square root 
transformation was performed to obtain a normal distribution 
for one stimulus: VAS pain elicited by tactile stimulation. 
Pearson correlation coefficients were calculated to determine 
the intercorrelations between the itch and pain reported for each 
stimulus and between the thresholds and itch and pain reported 
at the thresholds. In order to test the hypotheses, composite 
endpoints were made for both the tolerance thresholds and 
itch and pain scores separately by calculating the means of the 
standardized thresholds and means of the standardized itch and 
pain scores for the different stimuli (35). Pearson correlation 
coefficients were then calculated between attentional focus 
and these composite scores for the thresholds and itch and 
pain scores (one-tailed). Additional explorative analyses were 
further conducted by calculating the single correlations between 
sensory thresholds and the VAS ratings for itch and for pain for 
each stimulus separately (one-tailed). In addition, we studied the 
role of attentional focus as a mediator between personality and 
itch and pain sensitivity according to the procedure described 
by Baron & Kenny (36). A necessary condition for mediation is 
that a significant linear relation exists between the independent 
variable and mediator, independent variable and outcome, and 
mediator and outcome variable. Therefore these correlations 
were calculated with, as independent variables, neuroticism and 
anxiety sensitivity, as possible mediator attentional focus, and 
as outcome variables the measures of itch and pain sensitivity. 
Mediation is then specified by a decrease in the significant 
relationship between the independent variable and the outcome 
variable, when controlling for the mediator. 
Furthermore, all analyses were controlled by conducting partial 
correlation analyses for the following possible confounders: age, 
body mass index, educational level, menopausal status, medica-
tion intake and VAS itch and pain at the day of testing. Since these 
control variables did not significantly correlate with any of the 
measures for attentional focus and the same levels of significance 
were found when controlling for these variables by use of partial 
correlation analyses, the uncorrected data are presented.
RESULTS
Quantitative sensory testing outcome measures and 
outcome measures for attention
The means, SD and range of the thresholds and VAS 
scores for itch and pain elicited by the stimuli are 
presented in Table I. Means, SD and range of both 
measures of attentional focus are displayed in Table 
II. The itch and pain scores for the same QST stimulus 
were not significantly correlated for all applied stimuli 
(data not shown). There were also no significant 
correlations between the thresholds and itch or pain 
scores for the same stimulus for all applied stimuli, 
except for a significant correlation between the 
tolerance threshold of electrical stimulation and the 
pain score at this threshold (r = 0.37, p < 0.05). 
Association between attentional focus and tolerance 
thresholds
There were no significant associations between the me-
asures of attentional focus and the composite scores for 
the tolerance thresholds for the applied somatosensory 
stimuli (Table III). There were also no significant 
correlations when exploratively testing the single cor-
relations between attentional focus and the different 
measures of the tolerance thresholds for the tactile, 
electrical or cold pressor stimuli (Table III). 
Association between attentional focus and itch and 
pain elicited by the stimuli
The composite scores for itch and pain both were 
significantly correlated with the BVS, indicating that 
a greater attentional focus on bodily sensations was 
significantly associated with higher levels of itch and 
pain evoked by the somatosensory stimuli applied. 
In addition, the composite score for itch, but not the 
composite score for pain, was significantly correlated 
with the BSQ, indicating that a greater attention to the 
occurrence of sensations was significantly associated 
with higher levels of itch evoked by the somatosensory 
Table I. Means, standard deviations (SD) and range of tolerance 
thresholds and visual analogue scale (VAS) scores for itch and 
pain elicited by different somatosensory stimuli
Mean (SD) Range
Thresholds
Tactilea 13.0 (4.6) 6–20
Electricalb 7.2 (4.0) 1.5–15.0
Cold pressorc 55.6 (50.7) 4–180
Itch and pain ratings – VASd
Tactile
itch 0.9 (1.3) 0.0–4.0
pain 0.8 (1.1) 0.0–5.0
Electrical stimulation
itch 1.6 (2.2) 0.0–7.0
pain 2.9 (2.5) 0.0–8.5
Cold pressor
pain 4.5 (2.8) 0.0–8.5
Histamine
itch 2.9 (2.1) 0.0–7.0
pain 1.8 (2.1) 0.0–6.7
Capsaicin
itch 1.1 (1.4) 0.0–5.4
aTactile threshold: hair number out of a total of 20 von Frey 
monofilaments; belectrical threshold: electrical current in mA; ccold 
pressor immersion time in seconds.
dVAS itch/pain: score of itch/pain evoked by the stimuli on a visual 
analogue scale ranging from 0 to 10.
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stimuli (Table III). The explorative correlations for each 
of the stimuli separately further showed that a greater 
attention to the occurrence of sensations (BSQ) was 
significantly associated with a higher itch score during 
tactile, electrical, histamine, and capsaicin stimuli and 
to a higher pain score during the cold pressor test. In ad-
dition, a greater attentional focus on bodily sensations 
(BVS) was significantly correlated with a higher itch 
score for capsaicin application and a higher pain score 
for both histamine iontophoresis and the cold pressor 
test (see Table III). 
Role of personality characteristics
Means, SD and range of the questionnaires measuring 
neuroticism and anxiety sensitivity are displayed 
in Table II. Personality characteristics were not 
significantly associated with the measures of attentional 
focus or the thresholds or itch and pain scores at these 
thresholds. Consequently the personality character-
istics did not play a role in the relationship between 
attentional focus and itch and pain sensitivity to the 
somatosensory stimuli. 
DISCUSSION
Focusing attention on bodily sensations might play a 
role in heightened sensitivity or hypervigilance of pa-
tients with symptoms of itch or pain (5–7). In the present 
study, we therefore examined the role of attentional 
focus on bodily sensations on the experience of both itch 
and pain. A relatively high attentional focus on bodily 
sensations was associated with higher scores for itch 
and pain elicited by different somatosensory stimuli. 
Our results are consistent with previous studies in pain 
(8, 14) and preliminary results for itch (19), indicating 
that attentional focus, next to pain, also plays a role 
in the sensitivity to itch. This suggests that attentional 
focusing is a generic mechanism, which plays a role in 
the sensitivity to different somatosensory stimuli.
The association between heightened attentional focus 
on bodily sensations and increased sensitivity to itch and 
pain sensations could be analogous to anxiety related 
symptoms (37). Generally speaking, aggravation of 
common sensations could increase awareness of these 
sensations, which may in turn aggravate the occurrence 
or intensity of the sensations. This increased awareness 
of the occurrence of sensations could influence the 
interpretation and expectancy of consequences, which 
may lead to negative misinterpretations of normal phy-
siological sensations (37, 38). The combination of an 
increased awareness of bodily sensations and a negative 
interpretation of these sensations may, in turn, lead to a 
higher reporting of the frequency and/or intensity of a 
given sensation. These information processing mecha-
nisms are thought to play a role in the experience of 
pain (6, 7, 15) and similar mechanisms may also play 
a role in the experience of itch. Especially in patients 
with chronic itch and pain, attentional focus thus might 
be relevant in the high symptom reporting and, in turn, 
might also be involved in processes of both peripheral 
Table II. Means, standard deviations (SD) and range of both 
measures of attentional focus (BSQ and BVS) and the measures of 
the personality characteristics neuroticism and anxiety sensitivity 
(EPQ and ASI)
Mean (SD) Rangea
Attention to occurrence of sensations (BSQ) 1.86 (0.36) 1.13–2.87
Attentional focus (BVS) 3.42 (1.55) 1.32–6.81 
Neuroticism (EPQ) 6.13 (4.85) 0–22
Anxiety Sensitivity (ASI) 1.35 (0.66) 0.27–2.87
aTheoretical scale ranges of questionnaires: BSQ: 1–4; BVS: 0–10; EPQ: 
0–22; ASI: 0–4. 
BSQ: Body Sensations Questionnaire; BVS: Body Vigilance Scale; EPQ: 
Eysenck Personality Questionnaire; ASI: Anxiety Sensitivity Index.
Table III. Pearsons correlations between attentional focus on bodily 
sensations and the composite and single scores for the tolerance 
thresholds and visual analogue scale (VAS) scores for itch and 
pain elicited by different somatosensory stimuli
Attention to occurrence 
of sensations (BSQ)
Attentional 
focus (BVS)
Thresholds
Composite score for thresholdsa –0.22 –0.01
Tactileb –0.05 0.01
Electricalc –0.15 0.12
Cold pressord –0.21 –0.14
Itch and pain scores – VASe
Composite score for itcha 0.55*** 0.30*
Composite score for paina 0.05 0.50**
Tactile
itch 0.34* 0.13
pain –0.23 0.25
Electrical stimulation
itch 0.49** 0.24
pain –0.15 0.27
Cold pressor
pain 0.40* 0.52***
Histamine
itch 0.34* 0.13
pain 0.10 0.39*
Capsaicin
itch 0.43** 0.36*
*p < 0.05; **p < 0.01; ***p < 0.001 (one-tailed).
aComposite score for tolerance thresholds: means of the standardized scores 
for the tolerance thresholds for tactile, electrical and cold pressor stimuli. 
Composite score for VAS scores: means of the standardized scores for 
itch and pain evoked by the tactile, electrical, cold pressor, histamine, and 
capsaicin stimuli.
bTactile threshold: hair number out of a total of 20 von Frey monofilaments; 
cElectrical threshold: electrical current in mA; dCold pressor immersion 
time in seconds.
eVAS itch/pain: score of itch/pain evoked by the stimuli on a visual analogue 
scale ranging from 0 to 10.
Corresponding levels of significance were found after controlling for the 
variables age, body mass index, educational level, menopausal status, 
medication intake, and current itch and pain at the day of testing.
BSQ: Body Sensations Questionnaire; BVS: Body Vigilance Scale.
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and central sensitization. Future research might eluci-
date the role of attentional focus in central sensitization 
processes of itch and pain, for example by assessing 
temporal summation, hyperalgesia, or hyperknesis as 
measures for central sensitization of pain and itch. 
While the degree of attention paid to bodily sensations 
seemed to be related to reported levels of itch and pain, 
attentional focus was not associated with the tolerance 
thresholds. This is in line with the previous findings 
for the tolerance threshold for the cold pressor test (9) 
and suggests that attentional mechanisms particularly 
play a role in the subjective experience of sensations, 
probably reflecting the more cognitive-affective sensi-
tivity, while the tolerance to stimuli, reflecting the more 
sensory-discriminative part of sensitivity, may be more 
dependent on, for example, genetic factors (34, 39). 
With regard to the influence of personality on sensiti-
vity to itch and pain, we expected that attentional focus 
might be affected by anxiety-based personality charac-
teristics, thus that attentional focus might mediate the 
relationship between, for example, anxiety sensitivity 
and itch and pain reporting. However, our results show-
ed no association between personality and attentional 
focus or sensitivity to itch and pain. Our results, that 
anxiety sensitivity and neuroticism were not associated 
with the measures of attentional focus, are in line with 
earlier findings in healthy individuals (14, 40). However, 
mean scores of anxiety sensitivity and neuroticism were 
relatively low in this sample of healthy subjects, which 
may explain the low correlation with the level of itch and 
pain sensations experienced (20, 21). In future research 
it may be important to also include subjects with high 
levels of anxiety (e.g. generealized anxiety disorder) 
to investigate whether anxiety based mechanisms of 
attentional focus in relation to itch and pain sensitivity 
might be particularly relevant to subjects scoring high 
on anxiety measures (21). In addition, as it has been 
shown that not only anxiety processes, but also other 
emotional states such as depression play an important 
role in the perception of itch (41), future research should 
also focus on the role of emotional states such as depres-
sion in relation to attentional focus and the sensitivity to 
itch or pain. Also, the role of a threatening character of 
stimuli may be further explored, for example by giving 
catastrophic instructions about the stimuli.
Some limitations have to be taken into account. First, 
since for all subjects stimuli were applied in the same 
order, we cannot exclude habituation or priming effects 
due to the preceding stimuli. Although it was attempted 
to minimize interaction between stimuli, by intervals 
in-between the stimuli, in future research the sequence 
of stimuli applied could be alternated. Secondly, using 
composite scores for the different measures of mechani-
cal, electrical, chemical, and thermal stimuli might not be 
sensitive enough to study different sensory aspects of itch 
and pain sensitivity, while the explorative analyses of the 
single correlations of all measures might lead to possible 
problems of multiple testing and type I error. Thirdly, 
to get more insight into the causal effects of attentional 
mechanisms on sensitivity to itch and pain, it might be 
important to experimentally manipulate attentional focus, 
for example by using distraction tasks or attentional focu-
sing tasks (40). Fourthly, this study provides support for 
the role of attentional focus in itch and pain sensitivity of 
healthy female subjects. Since sensitivity to pain differs 
slightly between men and women (42), additional mecha-
nisms and their role in sensitivity to itch and pain have 
to be replicated in men. Fifthly, due to possible response 
bias, it may be preferable to combine the questionnaires 
with implicit tasks to measure pre-attentive processes 
(11). Sixthly, the items of the questionnaires measuring 
attentional focus are about anxiety-related complaints 
and are generally in contrast to the QST stimuli evoking 
mainly itch or pain. Correlations may be stronger if the 
attentional mechanisms concern sensations related to the 
specific applied stimuli or if they are of direct relevance 
for the subjects. Since itch and pain are highly relevant 
to patients with chronic itch and pain, respectively, it 
would be appropriate to include these patients in future 
research. For clinical purposes future research might 
focus on identifying and screening of patients at risk 
for disturbed attentional processes, followed by tailored 
treatment to reduce dysfunctional hypervigilance for 
physical symptoms of itch and pain.
In summary, the results of the present study indicate 
that a greater attentional focus on bodily sensations is 
not only relevant to the experience of pain, but also of 
itch, suggesting that a generic attentional focus on bodily 
sensation is a mechanism that plays a role in sensitivity 
to different physical sensations. Future research is needed 
to investigate whether mechanisms of attentional focus 
may also be involved in symptom reporting of patients 
with skin disease who suffer from chronic itch.
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